SCHEMBL19954244

SCHEMBL19954244

CC(C)NCc1cccc(C(=O)N2CCOCC2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.57
NPC1 O15118 1/20 0.57
TP53 P04637 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.54
ALDH1A1 P00352 1/20 0.54
ACACB O00763 1/20 0.52
HSP90AA1 P07900 1/20 0.50
HSP90AB1 P08238 1/20 0.50
KDM4E B2RXH2 1/20 0.50
HPGD P15428 1/20 0.50
IDO1 P14902 1/20 0.49
TDO2 P48775 1/20 0.49
PARP1 P09874 1/20 0.49
HRH3 Q9Y5N1 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
TSHR P16473 1/20 0.49
RECQL P46063 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17790201 0.86 RAB9A (0.60) RAB9ANPC1TP53SMN1; SMN2NPSR1
SCHEMBL10224025 0.83 RAB9A (0.60) RAB9ANPC1TP53SMN1; SMN2NPSR1
SCHEMBL19954243 0.82 RAB9A (0.60) RAB9ANPC1TP53SMN1; SMN2NPSR1
SCHEMBL13853835 0.81 TP53 (0.56) RAB9ANPC1TP53SMN1; SMN2NPSR1
SCHEMBL7901271 0.81 RAB9A (0.67) RAB9ANPC1TP53SMN1; SMN2NPSR1
SCHEMBL3863696 0.81 RAB9A (0.58) RAB9ANPC1TP53SMN1; SMN2NPSR1
SCHEMBL21016172 0.81 RAB9A (0.55) RAB9ANPC1TP53SMN1; SMN2NPSR1
SCHEMBL22387485 0.80 ALDH1A1 (0.60) RAB9ANPC1TP53SMN1; SMN2NPSR1
SCHEMBL19070392 0.80 ALDH1A1 (0.62) RAB9ANPC1TP53SMN1; SMN2NPSR1
SCHEMBL10272898 0.79 RAB9A (0.65) RAB9ANPC1TP53SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914740-B2 Tricyclic pyrido-carboxamide derivatives as rock inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-13 US disclosed